The Schinzel-Giedion syndrome is an infrequently described malformation syndrome, mainly characterized by a profound mental deficiency, a typical face including a midface hypoplasia, urogenital abnormalities, and minor radiographic features. Death prior to two year of age is the rule. A boy with typical features of the syndrome is described. He died at the age of 21 months. This is the first case of this syndrome reported from Croatia. The recurrence in only one of the 20 families, does not firmly sustain an autosomal recessive pattern of inheritance, although this still remains possible.

Download full-text PDF

Source

Publication Analysis

Top Keywords

schinzel-giedion syndrome
8
syndrome
5
croatian case
4
case schinzel-giedion
4
syndrome schinzel-giedion
4
syndrome infrequently
4
infrequently described
4
described malformation
4
malformation syndrome
4
syndrome characterized
4

Similar Publications

The management of children with syndromes associated with an increased risk of benign and malignant neoplasms is a complex challenge for healthcare professionals. The 2023 AACR Childhood Cancer Predisposition Workshop provided updated consensus guidelines on cancer surveillance in these syndromes, aiming to improve early detection, intervention, and reduce morbidity associated with such neoplasms. In this paper, we review several of the rare conditions discussed in this workshop.

View Article and Find Full Text PDF

Schinzel-Giedion syndrome (SGS) is a severe multisystem disorder characterized by distinctive facial features, profound intellectual disability, refractory epilepsy, cortical visual impairment, hearing loss, and various congenital anomalies. SGS is attributed to gain-of-function (GoF) variants in the SETBP1 gene, with reported variants causing canonical SGS located within a 12 bp hotspot region encoding SETBP1 residues aa868-871 (degron). Here, we describe a case of typical SGS caused by a novel heterozygous missense variant, D874V, adjacent to the degron.

View Article and Find Full Text PDF

Delayed Bone Age in a Child with a Novel Loss-of-Function Variant in Gene Sheds Light on the Potential Role of SETBP1 Protein in Skeletal Development.

Mol Syndromol

March 2024

Immunopathology and Cancer Biomarkers Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.

Introduction: gene variants that decrease or eliminate protein activity have been associated with phenotypes characterized by speech apraxia and intellectual disabilities. This condition, distinctly separated from Schinzel-Giedion syndrome, is referred to as autosomal dominant mental retardation 29 (ADR29).

Case Presentation: In this report, we present the case of a 6-year-old male patient exhibiting fine and global motor skill impairments along with expressive language delay.

View Article and Find Full Text PDF
Article Synopsis
  • The SETBP1 gene encodes a transcription factor with variants linked to diseases such as Schinzel Giedion Syndrome (SGS) and SETBP1 haploinsufficiency disorder, as well as hematological malignancies in adults.
  • Analysis of RNA-sequencing data showed that SETBP1 and its target genes are expressed differently across 31 human tissues, with distinct patterns related to transcriptional regulation, DNA binding, and mitochondrial function.
  • The study introduces a Shiny web application that allows researchers to explore the tissue-specific activity of SETBP1 and other transcription factors, aiding in the understanding of how tissue context affects gene expression and disease.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!